Hi-Tech Pharmacal Co. Inc. - PharmaTrack

Research and Markets (researchandmarkets.com/reports/c10480) has announced the addition of Hi-Tech Pharmacal Co. Inc. - PharmaTrack to their offering

(PRWEB) December 4, 2004 -- PharmaTrack is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that dont have adequate analyst coverage, making it a high-in-demand, value added research product. This report profiles Hi-Tech Pharmacal Co. Inc.

Each PharmaTrack Profile is packed with crucial data & information and in-depth analysis. The profile elaborates on the companys business structure and operations, products and services. It extensively discusses the companys financial performance and strategic imperatives from an investors perspective and provides a reliable outlook for the future.

Scope of the Report

- Provides key company data and analysis to industry players, which is vital to enhance business and competitor intelligence and facilitate decision making

- Analyzes the industry and the segment to which the company belongs in a concise manner.

- Compares the company vis-à-vis its peers in a detailed manner

- Discusses also the current industry status and the significant trends that influence the industry

- Tracks key initiatives of the company in the recent period across strategic areas of focus

- Analyzes the Strengths & Weaknesses of the company (SWOT Analysis)

- Analyzes the financial performance of the company for the most recently ended quarter and financial year across businesses, product/service categories and revenue streams

- Scopes comment on the companys outlook for the forthcoming period -- strategic and financial

- Supplementary information such the key industry players, overall industry financial and market performance, companys board members and senior management team, company and business overview, list of products and services, and stock movements for annual and three-year periods.

Company Brief 1

Key Highlights 1

- Stock Data -- Last 3 years to date 2

- Stock Data -- Last 52 weeks 2

Industry Overview 3

Company Overview 10

Management Structure 11

Shareholding Pattern 11

- Insider Ownership 11

- Institutional Ownership 12

- Public 12

Major Operations 12

- Manufacturing Facilities 12

- Products and Customers 12

- Marketing Efforts 13

- Ongoing Developments & Programs 13

Key Partnerships 13

Market Position -- Comparison with Industry Peers 14

Strategic Overview 15

- SWOT Analysis 15

Strategic Focus 20

- Focus on New Product Launches 20

- Enhancing Prospects in the Diabetes Market 21

Financial Performance 22

- Quarterly Performance- Final Quarter of Fiscal 2004 22

- Full --Year Performance 23

Risk Factors 25

Outlook 26

For more information visit http://www.researchandmarkets.com/reports/c10480

Laura Wood

Senior Manager

Research and Markets

press@researchandmarkets.com

Fax: +353 1 4100 980

###